Starbucks (SBUX) sales rise 7.2% as turnaround gains momentum, but 2027 revenue outlook signals a new test
Read More Pharma Industry News Ocugen secures FDA clearance to begin OCU400 gene therapy trial: What this means for patients with retinitis pigmentosa Find out how Ocugen’s FDA-approved OCU400 trial is shaping the future of gene therapy for retinitis pigmentosa. Read the full story today. byLavanyaDecember 11, 2021